IDEXX LABORATORIES INC /DE Acquisitions, Net of Cash Acquired
IDEXX LABORATORIES INC /DE (IDXX) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for the quarter ending 2025-06-30 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for fiscal 2024 was $76.69M.
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE payments to acquire businesses, net of cash acquired for fiscal 2022 was $11.51M, a 93.36% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $0.00 10-K · filed 2026-02-20 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $0.00 10-Q · filed 2025-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | -$306.00K derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | -$306.00K derived: sum of 3 quarters · filed 2026-02-20 | -$306.00K derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$306.00K derived: sum of 2 quarters · filed 2026-02-20 | -$306.00K derived: sum of 3 quarters · filed 2026-02-20 | $76.69M 10-K · filed 2026-02-20 |
| 2024-09-30 | -$306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$306.00K derived: sum of 2 quarters · filed 2025-11-03 | $76.69M 10-Q · filed 2025-11-03 | $76.69M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $77.00M 10-Q · filed 2025-08-04 | $77.00M derived: sum of 3 quarters · filed 2026-02-20 | $77.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $77.00M 10-Q · filed 2025-05-01 | $77.00M derived: sum of 2 quarters · filed 2026-02-20 | $77.00M derived: sum of 3 quarters · filed 2026-02-20 | $77.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $0.00 10-K · filed 2026-02-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-02-21 | $11.51M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $0.00 derived: sum of 2 quarters · filed 2025-02-21 | $11.51M derived: sum of 3 quarters · filed 2025-02-21 | $11.51M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $11.51M derived: sum of 2 quarters · filed 2025-02-21 | $11.51M derived: sum of 3 quarters · filed 2025-02-21 | $11.51M 10-K · filed 2025-02-21 |
| 2022-09-30 | $11.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $11.51M derived: sum of 2 quarters · filed 2023-11-01 | $11.51M 10-Q · filed 2023-11-01 | $23.76M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | $12.25M derived: sum of 3 quarters · filed 2024-02-22 | $16.91M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $12.25M derived: sum of 2 quarters · filed 2024-02-22 | $16.91M derived: sum of 3 quarters · filed 2024-02-22 | $168.99M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $12.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $16.91M derived: sum of 2 quarters · filed 2024-02-22 | $168.99M derived: sum of 3 quarters · filed 2024-02-22 | $173.42M 10-K · filed 2024-02-22 |
| 2021-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $156.74M derived: sum of 2 quarters · filed 2022-11-01 | $161.17M 10-Q · filed 2022-11-01 | $162.67M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $152.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $156.51M 10-Q · filed 2022-08-02 | $158.01M derived: sum of 3 quarters · filed 2023-02-16 | $158.01M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $4.42M 10-Q · filed 2022-05-04 | $5.92M derived: sum of 2 quarters · filed 2023-02-16 | $5.92M derived: sum of 3 quarters · filed 2023-02-16 | $5.92M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.50M derived: sum of 2 quarters · filed 2023-02-16 | $1.50M derived: sum of 3 quarters · filed 2023-02-16 | $1.50M 10-K · filed 2023-02-16 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $0.00 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $50.30M 10-K · filed 2022-02-16 | |||
| 2019-06-30 | $304.00K 10-Q · filed 2020-07-31 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $22.50M derived: sum of 2 quarters · filed 2021-02-12 | $22.50M 10-K · filed 2021-02-12 | |
| 2018-09-30 | $22.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $22.50M 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 | |||
| 2017-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $50.00K derived: sum of 2 quarters · filed 2020-02-14 | $12.23M derived: sum of 3 quarters · filed 2020-02-14 | $14.58M 10-K · filed 2020-02-14 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $12.18M derived: sum of 2 quarters · filed 2018-11-01 | $14.53M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $12.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $14.53M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $2.35M 10-Q · filed 2018-05-04 | |||
| 2016-12-31 | $1.96M 10-K · filed 2019-02-15 | |||
| 2015-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $9.92M derived: sum of 2 quarters · filed 2018-02-16 | $9.92M derived: sum of 3 quarters · filed 2018-02-16 | $10.30M 10-K · filed 2018-02-16 |
| 2015-09-30 | $7.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $7.82M derived: sum of 2 quarters · filed 2016-11-01 | $8.20M 10-Q · filed 2016-11-01 | $25.80M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $383.00K 10-Q · filed 2016-08-02 | $17.98M derived: sum of 3 quarters · filed 2017-02-17 | $24.34M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $383.00K 10-Q · filed 2016-04-29 | $17.98M derived: sum of 2 quarters · filed 2017-02-17 | $24.34M derived: sum of 3 quarters · filed 2017-02-17 | $24.34M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $23.95M derived: sum of 2 quarters · filed 2017-02-17 | $23.95M derived: sum of 3 quarters · filed 2017-02-17 | $25.11M 10-K · filed 2017-02-17 |
| 2014-09-30 | $6.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $6.36M derived: sum of 2 quarters · filed 2015-10-28 | $7.52M 10-Q · filed 2015-10-28 | $8.34M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $1.16M 10-Q · filed 2015-07-30 | $1.98M derived: sum of 3 quarters · filed 2016-02-17 | |
| 2014-03-31 | $1.16M 10-Q · filed 2015-04-28 | $1.98M derived: sum of 2 quarters · filed 2016-02-17 | ||
| 2013-12-31 | $822.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $10.92M 10-K · filed 2016-02-17 | ||
| 2013-09-30 | $10.10M 10-Q · filed 2014-10-24 | |||
| 2012-12-31 | $2.66M 10-K · filed 2015-02-17 | |||
| 2011-12-31 | $44.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $46.76M 10-K · filed 2014-02-18 | ||
| 2011-09-30 | $2.60M 10-Q · filed 2012-10-19 | |||
| 2009-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $7.91M 10-K · filed 2012-02-17 | ||
| 2009-09-30 | $6.68M 10-Q · filed 2010-10-22 | |||
| 2008-12-31 | $3.89M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |